Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 902219 Boston, MA

Position in ACRV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,580,871
+$346,371 QoQ
Shares Held
888,130
0.0% QoQ
Ownership
2.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 46 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ACRV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. ACRV ranks #135 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRV

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,580,871 888,130
2026-03-31 $1,234,500 888,130
2025-12-31 $2,140,393 888,130
2025-09-30 $1,607,515 888,130
2025-06-30 $1,056,874 888,130
2025-03-31 $1,802,903 888,130
2024-12-31 $5,346,542 888,130
2024-09-30 $6,216,910 888,130
2024-06-30 $5,151,154 888,130
2024-03-31 $6,350,129 888,130
2023-12-31 $4,369,599 888,130
2023-09-30 $8,490,522 888,130
2023-06-30 $11,510,164 888,130
2023-03-31 $11,270,369 888,130
2022-12-31 $10,369,716 900,149